D1000 Varejo Farma Participacoes (BSP:DMVF3) EBIT: R$94 Mil (TTM As of Mar. 2026)


BSP:DMVF3 D1000 Varejo Farma Participacoes SA BSP:DMVF3
78 GF Score
Price R$6.82
GF Value R$8.13
Valuation Modestly Undervalued
! 6 Warning Signs
View Full Analysis

What is D1000 Varejo Farma Participacoes EBIT?

D1000 Varejo Farma Participacoes BSP:DMVF3 -1.16% 78 EBIT is R$94 Mil as of Mar. 2026. GuruFocus rates BSP:DMVF3 with a GF Score™ of 78/100 and a GF Value™ of R$8.13 (Modestly Undervalued). The stock has 6 warning signs investors should review.

D1000 Varejo Farma Participacoes's earnings before interest and taxes (EBIT) for the three months ended in Mar. 2026 was R$-1 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Mar. 2026 was R$94 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. D1000 Varejo Farma Participacoes's annualized ROC % for the quarter that ended in Mar. 2026 was 0.00%. D1000 Varejo Farma Participacoes's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was -0.31%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. D1000 Varejo Farma Participacoes's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was 11.01%.


D1000 Varejo Farma Participacoes  (BSP:DMVF3) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

D1000 Varejo Farma Participacoes's annualized ROC % for the quarter that ended in Mar. 2026 is calculated as:

ROC % (Q: Mar. 2026 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Dec. 2025 ) + Invested Capital (Q: Mar. 2026 ))/ count )
=1.748 * ( 1 - 100% )/( (1531.603 + 1592.379)/ 2 )
=0/1561.991
=0.00 %

where

Invested Capital(Q: Dec. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=1949.154 - 371.638 - ( 45.913 - max(0, 573.366 - 620.264+45.913))
=1531.603

Invested Capital(Q: Mar. 2026 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=1978.743 - 363.371 - ( 22.993 - max(0, 585.126 - 618.418+22.993))
=1592.379

Note: The Operating Income data used here is four times the quarterly (Mar. 2026) data.

2. Joel Greenblatt's definition of Return on Capital:

D1000 Varejo Farma Participacoes's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 is calculated as:

ROC (Joel Greenblatt) %(Q: Mar. 2026 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Dec. 2025  Q: Mar. 2026
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=-2.204/( ( (567.989 + max(115.667, 0)) + (591.464 + max(126.955, 0)) )/ 2 )
=-2.204/( ( 683.656 + 718.419 )/ 2 )
=-2.204/701.0375
=-0.31 %

where Working Capital is:

Working Capital(Q: Dec. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(239.679 + 277.623 + 32.415) - (371.638 + 0 + 62.412)
=115.667

Working Capital(Q: Mar. 2026 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(235.613 + 292.697 + 34.703) - (363.371 + 0 + 72.687)
=126.955

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

D1000 Varejo Farma Participacoes's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Mar. 2026 )
=94.368/857.147
=11.01 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


D1000 Varejo Farma Participacoes EBIT Related Terms


D1000 Varejo Farma Participacoes EBIT Historical Data

* Premium members only.

The historical data trend for D1000 Varejo Farma Participacoes's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

D1000 Varejo Farma Participacoes EBIT Chart

D1000 Varejo Farma Participacoes Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EBIT
Get a 7-Day Free Trial Premium Member Only 5.27 42.40 55.25 63.39 75.68

D1000 Varejo Farma Participacoes Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.87 9.90 25.74 59.28 -0.55

D1000 Varejo Farma Participacoes EBIT Competitor Comparison

For the Pharmaceutical Retailers subindustry, D1000 Varejo Farma Participacoes's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


D1000 Varejo Farma Participacoes EV-to-EBIT vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, D1000 Varejo Farma Participacoes's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where D1000 Varejo Farma Participacoes's EV-to-EBIT falls into.


BSP:DMVF3
78GF Score
D1000 Varejo Farma Participacoes SA BSP:DMVF3
EBIT is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

D1000 Varejo Farma Participacoes EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was R$94 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT →
What does a EBIT of R$94 Mil mean?
D1000 Varejo Farma Participacoes (BSP:DMVF3) has a EBIT of R$94 Mil as of Mar. 2026. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on D1000 Varejo Farma Participacoes.
Is D1000 Varejo Farma Participacoes' EBIT too high?
D1000 Varejo Farma Participacoes' current EBIT is R$94 Mil. Overall, D1000 Varejo Farma Participacoes has a GF Score™ of 78/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does D1000 Varejo Farma Participacoes' EBIT compare to competitors?
D1000 Varejo Farma Participacoes' EBIT of R$94 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for a Healthcare Providers & Services company?
A good EBIT depends on the Healthcare Providers & Services industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on D1000 Varejo Farma Participacoes. D1000 Varejo Farma Participacoes's current EBIT is R$94 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is D1000 Varejo Farma Participacoes stock overvalued right now?
Based on GuruFocus' analysis, D1000 Varejo Farma Participacoes (BSP:DMVF3) is currently considered Modestly Undervalued. The stock's GF Value™ is R$8.13, compared to a current price of R$6.82 — trading 16.1% below its estimated fair value. The current EBIT is R$94 Mil. D1000 Varejo Farma Participacoes' overall GF Score™ is 78/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For D1000 Varejo Farma Participacoes (BSP:DMVF3), the current EBIT is R$94 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is D1000 Varejo Farma Participacoes (BSP:DMVF3) Overvalued in 2026?

Based on GuruFocus' analysis, D1000 Varejo Farma Participacoes stock appears to be undervalued. The current stock price of R$6.82 is trading 16.1% below its estimated GF Value™ of R$8.13. GuruFocus considers D1000 Varejo Farma Participacoes to be Modestly Undervalued.

Key valuation signals for BSP:DMVF3:

  • EBIT: R$94 Mil
  • GF Value™: R$8.13 vs. price of R$6.82 (16.1% below fair value)
  • GF Score™: 78/100 with 6 warning signs

No single metric tells the full story. See the BSP:DMVF3 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


D1000 Varejo Farma Participacoes Business Description

Address Cidade de Deus. Predio Amarelo, 2nd Floor, Osasco, SP, BRA, 6029900
D1000 Varejo Farma Participacoes SA invests in national or foreign pharmaceutical retail companies.
78GF Score

Get the complete analysis for BSP:DMVF3

EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

R$6.82
Price
R$8.13
GF Value